Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,663 | 58,393 | 62,812 | 67,038 | 12,357 |
| Receivables | 200 | 89 | 537 | 46 | 61 |
| TOTAL | $53,150 | $59,410 | $65,055 | $68,226 | $14,558 |
| Non-Current Assets | |||||
| PPE Net | 2,084 | 2,262 | 2,439 | 2,629 | 2,825 |
| Other Non-Current Assets | 700 | 700 | 700 | 700 | 700 |
| TOTAL | $2,784 | $2,962 | $3,139 | $3,329 | $3,525 |
| Total Assets | $55,934 | $62,372 | $68,194 | $71,555 | $18,083 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 1,946 | 4,149 | 2,548 | 2,336 | 1,958 |
| TOTAL | $3,398 | $6,093 | $5,617 | $5,753 | $5,433 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,452 | 1,944 | 3,069 | 3,417 | 3,475 |
| Other Non-Current Liabilities | 874 | 944 | 1,009 | 1,074 | 1,139 |
| TOTAL | $874 | $944 | $1,009 | $1,074 | $1,139 |
| Total Liabilities | $4,272 | $7,037 | $6,626 | $6,827 | $6,572 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 634 | 632 | 629 | 628 | 627 |
| Common Shares | 23 | 23 | 23 | 23 | 4 |
| Retained earnings | -80,201 | -76,029 | -69,484 | -65,839 | -62,456 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 65,586 |
| TOTAL | $51,662 | $55,335 | $61,568 | $64,728 | $11,511 |
| Total Liabilities And Equity | $55,934 | $62,372 | $68,194 | $71,555 | $18,083 |